| Literature DB >> 25490979 |
Martin Miguel Casco-Robles1, Tomoya Miura, Chikafumi Chiba.
Abstract
The adult newt has the ability to regenerate the neural retina following injury, a process achieved primarily by the retinal pigment epithelium (RPE). To deliver exogenous genes to the RPE for genetic manipulation of regenerative events, we isolated the newt RPE65 promoter region by genome walking. First, we cloned the 2.8 kb RPE65 promoter from the newt, Cynops pyrrhogaster. Sequence analysis revealed several conserved regulatory elements described previously in mouse and human RPE65 promoters. Second, having previously established an I-SceI-mediated transgenic protocol for the newt, we used it here to examine the -657 bp proximal promoter of RPE65. The promoter assay used with F0 transgenic newts confirmed transgene expression of mCherry fluorescent protein in the RPE. Using bioinformatic tools and the TRANSFAC database, we identified a 340 bp CpG island located between -635 and -296 bp in the promoter; this region contains response elements for the microphthalmia-associated transcription factor known as MITF (CACGTG, CATGTG), and E-boxes (CANNTG). Sex-determining region box 9 (or SOX9) response element previously reported in the regulation of RPE genes (including RPE65) was also identified in the newt RPE65 promoter. Third, we identified DNA motif boxes in the newt RPE65 promoter that are conserved among other vertebrates. The newt RPE65 promoter is an invaluable tool for site-specific delivery of exogenous genes or genetic manipulation systems for the study of retinal regeneration in this animal.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25490979 PMCID: PMC4436847 DOI: 10.1007/s11248-014-9857-1
Source DB: PubMed Journal: Transgenic Res ISSN: 0962-8819 Impact factor: 2.788
Fig. 1Nucleotide sequence of the C. pyrrhogaster RPE65 upstream region. Nucleotide numbers (relevant) appear on the left-hand side. CpG island is underlined. HpaII sites are double-underlined in italics. Repeat regions from newt are shown in gray boxes. Human and mouse RPE65 promoter-derived elements (Nicoletti et al. 1998; Boulanger et al. 2000) are shown in bold with parenthesis () and (), respectively. GSP1 and GSP2 reverse primers for genome walking are shown in dashed-underlined bold font. SOX9, SRY, CRX, E-box, and MITF response elements are shown in bold. CAAT and TATA boxes are highlighted in green. Inverted elements on the minus strand are indicated with a (-). (Color figure online)
Fig. 2Schematic comparison of the RPE65 promoter among vertebrates. The vertebrate RPE65 upstream promoter regions (2.8 kb from ATG start codon) were analyzed by MEME pattern motif recognition and TRANSFAC 6.0 software. All vertebrates contained at least one MITF response site, a critical factor for RPE development. The consensus sequences for the motifs described herein are shown in Tables S 2–6 Online Resource. In most higher vertebrates, motif boxes 1, 2, and 3 have a conserved distribution proximal to the ATG codon. Motif boxes 1 and 2 contain nuclear factor 1 (NF-1) and activating enhancer binding protein 4 (AP-4); both are derived from mammalian promoters. Motif 2 was found to be rich in CRX elements. Motif 3 contains the 5′ UTR. NF-1, AP-4, and the 5′ UTR have been shown to be key elements for driving a luciferase reporter gene in mouse and human promoters (Boulanger et al. 2000; Nicoletti et al. 1998). Sequence sites for motif boxes 4 and 5 have not been previously characterized in mammalian promoters (Boulanger et al. 2000; Nicoletti et al. 1998). A TOMTOM motif scan revealed that motif 4 contains tentative elements with sequence similarity values of p < 0.01 for the neural retina leucine zipper (NRL), the sex-determining region Y box (SRY) and FOXO1. Motif 5 shares sequence similarity with LHX2 (p < 0.005). Double underlining denotes an annotated mRNA site upstream of the RPE65 promoter. The accession numbers corresponding to the above species are shown in Table S1 Online Resource. RPE65b is the fish (D. rerio) RPE65 ortholog previously described by Schonthaler et al. (2007)
Fig. 3RPE65 proximal promoter (−657 bp) assay in F0 transgenic newt larvae (C. pyrrhogaster). a Schematic representation of the transgene construct. b No detection of mCherry expression at stage 10 (blastula). c Stage 24 (early tailbud) onset of mCherry expression localized in the developing optic cup of the dorsal posterior margin, indicated with a white arrowhead. D dorsal, V ventral. d Stage 33 (tailbud) showing mCherry expression in the midbrain and posterior eye margin. e Bright field image of (d). FB forebrain, MB midbrain, HB hindbrain, GS gill slits. (d, e) White arrowheads denote mCherry, and the white dotted arcs indicate the posterior eye margin. f Stage 40 (early swimming larva) showing induction of pigmentation in the eye. Inset (dashed White Square) shows a magnified image of the developing eye expressing mCherry denoted by the white arrowhead (g). h Stage 59 (mature larva) showing a heavily pigmented eye. Yellow arrowhead indicates auto-fluorescence. i PCR detection of cpRPE65-mCherry01 in genomic DNA from stage 59 F0 transgenic larvae. P Positive control cpRPE65-mCherry01 plasmid; T1 transgenic larva genomic DNA sample 1; T2 transgenic larva genomic DNA sample 2; C Negative control wild-type genomic DNA. j Promoter activity in the retinal pigment epithelium (RPE). ONL outer nuclear layer; INL inner nuclear layer; GCL ganglion cell layer. k Magnification of dashed white rectangle in (j). l Magnification of dashed white rectangle in (j), showing mCherry/bright field merged image of RPE apical microvilli. m, n Immunostaining of a retinal section with an anti-mCherry antibody. Signal was visualized by DAB treatment (brown). Black and yellow arrowheads indicate the RPE cell nucleus. o Negative control (without anti-mCherry antibody). Dashed black and white lines in (m, n, o) indicate the apical microvilli of the RPE. Scale bars, b–e 0.5 mm, f 2.0 mm, g–h 0.4 cm, j–o 50 μm. (Color figure online)
Optimization of cpRPE65-mCherry01 F0 generation transgenic newts
| DNA pga/egg | Eggs injectedb | Survival St.10 blastula (%) | mCherry expression | Survivald St. 59 (%) | ||||
|---|---|---|---|---|---|---|---|---|
| Developing eye (%) | St. 59 RPEc | |||||||
| ND | Avg. | Strong | + | – | ||||
| 160 | 120 | 22 (18) | 8 | 11 (50) | 3 (13.6) | 4/5 | 1/5 | 9 (41) |
| 100 | 112 | 45 (40) | 32 | 9 (20) | 4 (9) | 3/3 | 0/3 | 23 (47) |
| 80 | 103 | 68 (66) | 60 | 6 (9) | 2 (3) | 2/2 | 0/2 | 46 (68) |
| 40 | 108 | 77 (71) | 74 | 3 (4) | 0 | 2/2 | 0/2 | 64 (83) |
| 0 | – | 64e (97) | – | – | – | – | – | 59 (92) |
ND not detected, St. stage, RPE retinal pigment epithelium, Avg. average
apg is the total mass of cpRPE65-mCherry01 including the vector backbone
bThe injection volume was fixed at 2 nL/egg. I-SceI enzyme concentration was fixed at 1× 10–3 U/egg
cA subset of the average mCherry-expressing embryos were reared until stage 59 and their eye sections were prepared as shown in Fig. 3j–o
dBased on surviving blastula embryos
eViability control group (n = 66)